Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02956291 · ClinicalTrials.gov registry record · NA
Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors
A NA study of Brain Tumor, sponsored by Case Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 172
- Enrollment target
- 1
- Study location
NCT02956291: Active NA study of Brain Tumor, sponsored by Case Comprehensive Cancer Center.
NCT02956291 is a NA study of Brain Tumor that is active but no longer recruiting, run by Case Comprehensive Cancer Center. The registered enrollment target is 172 participants, below the 279-participant average among 69 other Brain Tumor trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02956291, a NA study of Brain Tumor, is active but no longer recruiting, sponsored by Case Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research study is to test new methods that could improve diagnosis and assessment of brain tumors. One of these methods is a new MR (magnetic resonance) imaging technique called magnetic resonance fingerprinting (MRF), which allows for rapidly scanning the patient and provides quantitative information on tumor tissue. The investigators will compare the data gathered from MR Fingerprinting with other imaging tests, clinical information, treatment details and biopsy results to evaluate the accuracy of this new technique.
Primary Outcome
Relaxometry time is the measurement of relaxation times from MR images and is the quantitative imaging technique that measures the exact T1 and T2 times of tissue.: T1 and T2 are imaging sequences. T1 is used for visualizing clear anatomy and fat, while T2 is used for detecting inflammation, edema and fluid buildup.
Conditions Studied
Interventions
- DEVICE Magnetic Resonance Fingerprinting
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2026-06 |
| Phase | NA |
What the registry record for NCT02956291 still lists
NCT02956291 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, below the 279-participant average among 69 other Brain Tumor trials with a reported enrollment target (38% lower).
The record links to 1 condition, with Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Resonance Fingerprinting is the first listed.
NCT02956291 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02956291 about?
NCT02956291 is a clinical study titled "Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors". The purpose of the research study is to test new methods that could improve diagnosis and assessment of brain tumors. One of these methods is a new MR (magnetic resonance) imaging technique called magnetic resonance fingerprinting (MRF), which allows for rapidly scanning the patient and provides qua...
What is the current status of trial NCT02956291?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 172 participants. The study started on 2017-02-15. Estimated completion is 2026-06.
What conditions does trial NCT02956291 study?
This clinical trial studies the following conditions: Brain Tumor.
What interventions are being tested in trial NCT02956291?
The interventions under investigation include: Magnetic Resonance Fingerprinting (DEVICE).
Who is sponsoring clinical trial NCT02956291?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02956291 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02956291's enrollment target sits among peer trials
172 13th of 69 higher than 57 of 69 other Brain Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
RECRUITING · NA
-
Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors
RECRUITING · NA
-
Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption
RECRUITING · NA
-
Ommaya Reservoir Placement for Brain Tumor Biomarker Access
RECRUITING · NA
-
Mapping of Human Cognition
RECRUITING · NA
-
LITT Followed by Hypofractionated RT for Recurrent Gliomas
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI